52.12
+0.08
+(0.15%)
At close: 8:10:36 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 13 |
| Avg. Estimate | 1.09B | 1.11B | 4.43B | 4.82B |
| Low Estimate | 1.08B | 1.07B | 4.39B | 4.71B |
| High Estimate | 1.1B | 1.13B | 4.47B | 4.87B |
| Year Ago Sales | 910.83M | 942.31M | 4.01B | 4.43B |
| Sales Growth (year/est) | 19.86% | 17.45% | 10.40% | 8.75% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CIE1.F | -- | -- | -- | -- |
| S&P 500 | 6.74% | 5.74% | 9.21% | 14.18% |
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 3/12/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/12/2025 |
| Upgrade | Northland Capital Markets: Market Perform to Outperform | 3/12/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/12/2025 |
| Maintains | Rosenblatt: Neutral to Neutral | 3/12/2025 |
| Maintains | Needham: Buy to Buy | 3/12/2025 |